Concepedia
Statistics
Publications
7
Citations
404
H-Index
Active since
2013
Affiliations
Heidelberg University(Current)
German Cancer Research Center
National Center for Tumor Diseases
University Hospital Heidelberg
DKFZ-ZMBH Alliance
Petra Rübmann is an author at Heidelberg University specializing in oncology, molecular oncology, and medicine.
Publications per year
2013–2021
mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy
Markus Weiler, Jonas Blaes, Stefan Pusch et al. · Proceedings of the National Academy of Sciences · 2013 · 198 citations · Full text
Medicine, Cancer Biology, Oncology +17
Glioma cell VEGFR-2 confers resistance to chemotherapeutic and antiangiogenic treatments in PTEN-deficient glioblastoma
Felix Sahm, Jonas Blaes, Matthias Osswald et al. · Oncotarget · 2015 · 53 citations · Full text
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Dominic Schmid, Uwe Warnken, Pauline Latzer et al. · Journal of Neurochemistry · 2021 · 43 citations · Full text
Medicine, Biochemistry, Oncology +17
Inhibition of CD95/CD95L (FAS/FASLG) Signaling with APG101 Prevents Invasion and Enhances Radiation Therapy for Glioblastoma
Jonas Blaes, Carina M. Thomé, Philipp‐Niclas Pfenning et al. · Molecular Cancer Research · 2018 · 35 citations · Full text
Medicine, Oncology, Pharmacology +17
Identification and Characterization of Cancer Cells That Initiate Metastases to the Brain and Other Organs
Anna S. Berghoff, Yunxiang Liao, Matthia A. Karreman et al. · Molecular Cancer Research · 2020 · 35 citations · Full text
Medicine, Cell Biology, Oncology +17
1–5 of 7